Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Acute Chagas disease without cardiac involvement (B57.100) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is b
Acute Chagas disease with myocarditis () is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Acute Chagas disease with cardiovascular involvement () is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is bein
Acute Chagas disease with cardiac involvement (B57.000) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is bein
African trypanosomiasis (sleeping sickness) is transmitted by tsetse fly; sub-Saharan Africa, up to 80% prevalence in some foci. Early fever/rash/edema/lymphadenopathy; later meningoencephalitis. East African = rapid; West African = chronic sleeping sickn
传染科Trypanosoma brucei rhodesiense infection [East African sleeping sickness] (B56.100x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed p
Rhodesian trypanosomiasis (B56.100) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Trypanosoma brucei gambiense infection [West African sleeping sickness] (B56.000x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pat
Gambian trypanosomiasis (B56.000) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Leishmaniasis (B55.900) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Mucosal leishmaniasis (B55.200x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Lymph node kala-azar (B55.200x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Mucocutaneous leishmaniasis (B55.200) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Cutaneous leishmaniasis [dermal kala-azar] (B55.100x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is bei
Post-kala-azar dermal leishmaniasis (B55.000x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being comp
Kala-azar is chronic endemic L. donovani infection, formerly north of Yangtze River. Source: patients/infected dogs; sandfly vector May-August. Amastigotes in patient blood develop into flagellates in sandfly; 7 days later re-injects. Parasite lives in bl
传染科Leishmaniasis is caused by Leishmania species; divided into visceral (VL), cutaneous (CL), mucocutaneous (ML). VL = kala-azar by L. donovani; chronic fever, hepatosplenomegaly, leukopenia, hypergammaglobulinemia.
传染科Malaria relapse (B54.x00x008) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Pregnancy malaria (B54.x00x007) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Infantile malaria (B54.x00x006) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
|